Figure 2: Changes in body weight from baseline to the end of treatment at week 26 associated with the treatment policy estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
However, its important to note that, like the billing cycle, the 30-day countdown starts the day you sign up
You purchase a program, receive your medication, and reorder only if you choose to
Because both medications treat diabetes and improve metabolic health, the comparison helped researchers isolate possible effects specific to GLP-1 drugs
Our medical experts play a pivotal role in guiding patients through dosage adjustments and administration techniques, ensuring semaglutide therapy aligns with individual health goals and effectively manages any side effects that may arise